According to a new report by Polaris Market Research, the global mesenchymal stem cells (MSCs) market was valued at USD 3.37 billion in 2024 and is projected to reach USD 11.26 billion by 2034, expanding at a CAGR of 12.9% over the forecast period. Growth is underpinned by rising demand for personalized medicine, advancing biomanufacturing techniques, and expanding applications of...